| Primary |
| Hormone Replacement Therapy |
68.9% |
| Contraception |
16.0% |
| Menopause |
1.6% |
| Arteriosclerosis |
1.5% |
| Breast Cancer |
1.3% |
| Menopausal Symptoms |
1.3% |
| Drug Use For Unknown Indication |
1.2% |
| Off Label Use |
1.2% |
| Cardiac Disorder |
1.0% |
| Cancer Pain |
0.8% |
| Hypertension |
0.6% |
| Antiretroviral Therapy |
0.6% |
| Endometrial Cancer |
0.6% |
| Arthralgia |
0.5% |
| Breast Cancer Metastatic |
0.5% |
| Menstrual Discomfort |
0.5% |
| Anxiety |
0.4% |
| Asthma |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Depression |
0.4% |
|
| Breast Cancer Female |
57.0% |
| Breast Cancer |
11.6% |
| Unintended Pregnancy |
7.5% |
| Progesterone Receptor Assay Positive |
4.4% |
| Drug Ineffective |
3.3% |
| Ovarian Cancer |
2.5% |
| Metrorrhagia |
2.0% |
| Inappropriate Schedule Of Drug Administration |
1.3% |
| Weight Increased |
1.3% |
| Vaginal Haemorrhage |
1.2% |
| Breast Cancer In Situ |
1.1% |
| Injection Site Reaction |
1.1% |
| Product Quality Issue |
0.9% |
| Injection Site Atrophy |
0.8% |
| Menorrhagia |
0.8% |
| Oestrogen Receptor Assay Positive |
0.8% |
| Incorrect Dose Administered |
0.7% |
| Dysmenorrhoea |
0.6% |
| Injection Site Pain |
0.6% |
| Urticaria |
0.6% |
|
| Secondary |
| Hormone Replacement Therapy |
81.8% |
| Menopausal Symptoms |
5.1% |
| Menopause |
4.8% |
| Hypertension |
1.6% |
| Oestrogen Replacement Therapy |
0.8% |
| Depression |
0.7% |
| Cardiac Disorder |
0.5% |
| Osteoporosis |
0.5% |
| Thyroid Disorder |
0.4% |
| Anxiety |
0.4% |
| Contraception |
0.4% |
| Pain |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Blood Pressure |
0.4% |
| Hot Flush |
0.4% |
| Diabetes Mellitus |
0.3% |
| Breast Cancer |
0.3% |
| Hypothyroidism |
0.3% |
| Prophylaxis |
0.3% |
| Drug Use For Unknown Indication |
0.3% |
|
| Breast Cancer Female |
39.6% |
| Breast Cancer |
29.7% |
| Breast Cancer Metastatic |
17.7% |
| Contralateral Breast Cancer |
1.9% |
| Invasive Ductal Breast Carcinoma |
1.5% |
| Ovarian Cancer |
1.3% |
| Progesterone Receptor Assay Positive |
1.2% |
| Breast Cancer In Situ |
1.0% |
| Pulmonary Embolism |
0.9% |
| Breast Cancer Recurrent |
0.9% |
| Thrombosis |
0.7% |
| Deep Vein Thrombosis |
0.6% |
| Unintended Pregnancy |
0.6% |
| Weight Increased |
0.4% |
| Cerebrovascular Accident |
0.4% |
| Cardiac Disorder |
0.3% |
| Invasive Lobular Breast Carcinoma |
0.3% |
| Metastases To Lymph Nodes |
0.3% |
| Oestrogen Receptor Assay Positive |
0.3% |
| Ovarian Cancer Metastatic |
0.3% |
|
| Concomitant |
| Prophylaxis |
20.3% |
| Drug Use For Unknown Indication |
16.6% |
| Breast Cancer |
7.1% |
| Metastases To Bone |
6.7% |
| Product Used For Unknown Indication |
6.6% |
| Contraception |
4.9% |
| Hiv Infection |
4.7% |
| Breast Cancer Recurrent |
4.5% |
| Crohn's Disease |
3.5% |
| Pain |
3.0% |
| Hormone Replacement Therapy |
2.7% |
| Hypertension |
2.6% |
| Abdominal Pain |
2.5% |
| Metastases To Liver |
2.4% |
| Osteoporosis Prophylaxis |
2.2% |
| Rheumatoid Arthritis |
2.0% |
| Breast Cancer Metastatic |
1.9% |
| Osteoporosis |
1.9% |
| Depression |
1.9% |
| Metastases To Lung |
1.9% |
|
| Vomiting |
11.7% |
| Pneumonia |
6.6% |
| Weight Decreased |
6.6% |
| Interstitial Lung Disease |
5.8% |
| Vulval Abscess |
5.8% |
| Breast Cancer |
5.1% |
| Neutropenia |
5.1% |
| Respiratory Failure |
5.1% |
| Suicidal Ideation |
5.1% |
| Bicytopenia |
4.4% |
| Pulmonary Embolism |
4.4% |
| Staphylococcal Infection |
4.4% |
| Vaginal Haemorrhage |
4.4% |
| Chest Pain |
3.6% |
| Lymphopenia |
3.6% |
| Nephrolithiasis |
3.6% |
| Photopsia |
3.6% |
| Syncope |
3.6% |
| Transient Ischaemic Attack |
3.6% |
| Venous Insufficiency |
3.6% |
|
| Interacting |
| Contraception |
54.5% |
| Onychomycosis |
27.3% |
| Bipolar Disorder |
9.1% |
| Drug Use For Unknown Indication |
9.1% |
|
| Metrorrhagia |
50.0% |
| Injection Site Atrophy |
33.3% |
| Unintended Pregnancy |
16.7% |
|
